Medicines List

Select category
  • Description

    Cordacare Plus is a fixed-dose combination product containing lisinopril, an inhibitor of angiotensin converting enzyme (ACE) and hydrochlorothiazide, a thiazide diuretic. Lisinopril works by making blood vessels widen. Hydrochlorothiazide helps get rid of water and salts, such as sodium, in urine.

    Indications

    Fixed-dose combination Cordacare Plus (10 mg or 20 mg lisinopril and 12.5 mg hydrochlorothiazide) is indicated for the treatment of mild to moderate hypertension in patients who have been stabilised on the individual components given in the same proportions.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 10 mg/12.5 mg, 20 mg/12.5 mg tablets

  • Description

    Amarhyton is a Class IC antiarrhythmic agent used in the treatment of severe symptomatic life-threatening ventricular arrhythmias and supraventricular arrhythmias.

    Indications

    Amarhyton is used for treatment of:
    – AV nodal reciprocating tachycardia; arrhythmias associated with Wolff-Parkinson-White Syndrome and similar conditions with accessory pathways, when other treatment has been ineffective;
    – Severe symptomatic and life-threatening paroxysmal ventricular arrhythmia which has failed to respond to other forms of therapy. Also where other treatments have not been tolerated;
    – Paroxysmal atrial arrhythmias (atrial fibrillation, atrial flutter and atrial tachycardia) in patients with disabling symptoms after conversion provided that there is definite need for treatment on the basis of severity of clinical symptoms, when other treatment has been ineffective. Structural heart disease and/or impaired left ventricular function should be excluded because of the increased risk for pro-arrhythmic effects.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 50 mg; 100 mg; 150 mg prolonged-release capsules, hard

  • Description

    Pizona contains pioglitazone.
    Pizona helps controlling the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces.

    Indications

    Pioglitazone is indicated for treatment of type 2 diabetes mellitus.

    as monotherapy:
    – in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance.

    as dual oral therapyin combination with:
    – metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin;
    – a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea.

    as triple oral therapyin combination with:
    – metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 15 mg, 30 mg, 45 mg tablets

     

  • Description

    ContaMedia Ioh is a “contrast medium”. This medicine is for diagnostic use only. It is used only to help identify an illness.

    Indications

    ContaMedia Ioh is given before an X-ray to make the picture that your doctor takes clearer.
    – Once injected, it can help your doctor tell apart normal or abnormal appearance and shape of some organs in your body;
    – It can be used for X-rays of your urinary system, spine or blood vessels, including the blood vessels of the heart;
    – In some people, this medicine is given before or during a head or body scan using computed tomography. This is a type of scan that uses X-rays;
    – It can also be used to examine your salivary glands, stomach and intestines, as well as to examine body cavities, such as those in the joints or uterus and ovarian tubes.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 350 mgI/mL solution for injection